JPRN-UMIN000013964已完成未知
n-blinded Multicenter Study to Assess the Safety and Efficacy of Robotic-assisted (da Vinci surgical system, DVSS) Laparoscopic Partial Nephrectomy for Renal Cell Carcinoma Patients - Un-blinded Multicenter Study of Robotic-assisted Laparoscopic Partial Nephrectomy
Kobe University Graduate School of Medicine0 个研究点目标入组 118 人开始时间: 2014年5月15日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 118
研究概览
简要总结
The achievement rate of the primary endpoint was 91.3% (95%CI:84.1-95.9%). It was significantly higher than the preset threshold (23.3%).
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1)multiple cancer 2)history of kidney transplantation. 3)therapies for renal cell cancer in the past 6 months. 4)unable to withdrawal of anticoagulation 5)anemia or hemorrhagic tendency requiring transfusion 6)obesity(Body Mass Index:BMI>=35) 7)dialysis patient. 8)pregnant, suspected of being pregnant, or lactating woman. 9)difficult to participate the study due to psychiatric disorder or psychological symptom. 10)inappropriate by the investigator or sub-investigator at the hospital (site) for any other reasons.
研究者
相似试验
已完成
不适用
A phase II study about the efficacy of an intervention of excercise therapy on the adjuvant chemotherapy for pancreatic cancer: Exercise-PC StudyJPRN-UMIN000030124Wakayama Medical University43
进行中（未招募）
不适用
n-blinded Multicenter Study of Robotic-assisted Laparoscopic Partial NephrectomycT1 Renal CancerJPRN-jRCT1052190004Masato Fujisawa100
已完成
不适用
Multicenter Phase II Clinical Study on the Safety and Efficacy of Nilotinib in Patients with Chronic Myelogenous Leukemia-Chronic Phase and Major Molecular ResponseChronic Myelogenous LeukemiaJPRN-UMIN000005903Cooperative study among the East Japan CML Study Group, Shimousa Hematology Study Group, Leukemia Study Group in Mie, Niigata CML Study Group and the NPO Tohoku Hematology Expert Meeting120
招募中
不适用
A Study to Evaluate the Safety and Effectiveness of Injectable Gel for Correction of Infraorbital Hollowing in Chinese PopulationInfraorbital HollowingNCT06394076Sinclair Pharmaceuticals Limited172
已完成
不适用
Multicenter Clinical Study Evaluating the Safety and Efficacy of Dasatinib Treatment and its Discontinuation in Patients with Chronic Phase Chronic Myelogenous Leukemia who had Reached Complete Molecular Response during Imatinib TherapyChronic Phase Chronic Myelogenous LeukemiaJPRN-UMIN000007221Juntendo University School of Medicine40